Technetium (/tɛkˈniːʃiəm/) is a chemical element with symbol Tc and atomic number 43. It is the element with the lowest atomic number in the periodic table that has no stable isotopes:every form of it is radioactive. Nearly all technetium is produced synthetically, and only minute amounts are found in nature.
Technetium is a group 7 transition metal with symbol Tc and atomic number 43. It is a silvery-gray metal, the first element produced artificially. All its isotopes are radioactive. Its states range from +4 to +7, with +7 (pertechnetate) the most stable in oxidizing media. Its name comes from Greek technetos (artificial).
Tc + 3 Cl2 -> TcCl4
Technetium reacts with chlorine to form technetium tetrachloride, a bluish-gray solid that is one of its most important compounds.
Tc + 2 H2SO4 -> Tc(SO4)2 + H2
Technetium reacts with hot concentrated sulfuric acid, releasing hydrogen and forming technetium sulfate.
| Compound | Formula | Use or importance |
|---|---|---|
| Technetium(V) peroxotungstate | Tc2O7 | Orange solid; getter precursor and oxidant |
| Technetium hexafluoride | TcFs6 | Yellow solid; getter precursor and used in purification procedures |
| Technetium dichloride | TcCl4 | Bluish-gray solid; getter precursor and surface components |
Technetium has no stable isotopes. The longest-lived is technetium-97 (4.2-million-year half-life). Technetium-99 (211,000 years) is the main fission by-product. Technetium-99m, a metastable state, has a 6-hour half-life and is the workhorse of diagnostic imaging.
Essentially absent in nature; traces of technetium-99 arise in uranium ores by spontaneous fission. Virtually all supply comes from nuclear reactors as fission product, separated during fuel reprocessing, or from molybdenum-99 decay in generators.
Carlo Perrier and Emilio Segre identified it in 1937 in molybdenum bombarded with deuterons at Berkeley. They named it technetium for being the first element made artificially. Later production of Tc-97 and Tc-99 confirmed the discovery and opened nuclear medicine.
Nearly all use is technetium-99m medical imaging: tens of millions of scans yearly for heart, bone, kidney and organ studies. Research uses tracers to follow chemical and biological processes in specialized labs.
Pertechnetate eluted from Mo-99/Tc-99m generators is kit-built into radiopharmaceuticals (sestamibi, MDP, DTPA). Fluoride and chloride serve fluorine chemistry and precursor synthesis.
Technetium is not essential. Medical Tc-99m doses are small, short-lived and mainly excreted in urine; the gamma energy suits imaging while activity fades after the scan. Safety holds only at controlled clinical doses with supervision.
All isotopes need radiological control: shielding, containment, waste routing. Tc-99 has a very long half-life and must not disperse. Labs handling it need licensed facilities and procedures.
Environmental technetium is anthropogenic from reactors, reprocessing and fallout. Pertechnetate is mobile in water, so releases are strictly limited and monitored; generators and hospitals return waste to controlled circuits.
One element feeds millions of scans: its 140 keV gamma rays escape the body for standard cameras, its 6-hour half-life limits patient dose, and generator supply fits hospitals. Kits bind it to molecules targeting heart, bone or kidneys.
Depending on the carrier molecule: heart blood flow, bone metabolism, kidney function and selected organs. Tc-99m maps distribution; diagnosis joins images with symptoms, history and other tests.
Same protons and neutrons, different nuclear energy: Tc-99m is the metastable excited state decaying by gamma emission in ~6 hours; Tc-99 is the ground state lasting ~211,000 years. Hence diagnostic use versus long-lived waste.
Six-hour half-life forbids stockpiling; hospitals rely on Mo-99 production, processing and fast transport. Research-reactor outages or logistics breaks cut availability, driving alternative production methods.
Molybdenum-99 fixed on a column decays to Tc-99m. Saline washed through elutes sodium pertechnetate while Mo-99 stays behind. This gives fresh short-lived doses on site without moving each dose from a distant plant.
Mainly ~140 keV gamma photons detectable by conventional cameras. They exit the body to build distribution images, and short half-life lets activity decay after the exam. Choice balances nuclear and clinical practicality.
Yes. Its isotopes follow distribution and transformation in experiments: radiopharmaceuticals map physiology, complexes probe coordination chemistry. Isotope, chemical form and detector set the use; radioactivity needs licensed setups.
Main sources consulted: PubChem, Royal Society of Chemistry, NIST, IUPAC. Last revision: November 2026.